Archiwum hase³
invasive infections | cervical lymphadenopathy | Shirmer’s test | fluorescein test | tear film stability | tear film | replantation replantacja | Hanks’ solution | natural fibers | synthetic fibers | primary depression | secondary depression | ischemic cerebral stroke | secondary epilepsy | idiopathic epilepsy | larval epilepsy | latent epilepsy | vasomotor epilepsy | autonomic epilepsy | cerebral embolism | paroxysmal atrial fibrillation | cardioversion | Wilms’ tumor | hemoptysis | bronchofiberoscopy | idiopathic epilepsy | larval epilepsy | latent epilepsy | vasomotor epilepsy | autonomic epilepsy | secondary epilepsy | motor disorders | eradication treatment | eradication therapy | Proton pump inhibitors | enterochromaffin cells {EC} | topical calcineurin inhibitors | collagen synthesis | calcineurin | diabetic nephropathy | nonpharmacologic therapy | psychogenic pain | psychalgia | nursing diagnosis | nursing process | non-invasive positive pressure ventilation {NIPPV} | Ciclesonide | omalizumab | β2-adrenoreceptor agonists | extracellular space | intracellular space | hemostatic disturbances | mitochondrial diabetes | monogenic | lipoatrophic diabetes | thrombolytic therapy | multiagent therapy | multidrug therapy | warning symptoms | perfusion scintigraphy of myocardium | electrocardiographic exercise test | familial hypercholesterolemia {FH} | LDL-apheresis | cluster headache attack | Cluster headache syndrome | primary headache | secondary headache | opioids | non-cancer pain | nonmalignant pain | primary tuberculosis | post-primary tuberculosis | elastin | aortic aneurysm | aneurysms of peripheral arteries | cerebral ischemic stroke | phlebotropic drugs | lymphedema | oestrogens receptors | isoflavones | genistein | daidzein | aspirin resistance | central obesity | atherogenic dyslipidaemia | Cardiac neurosis | Occupational neurosis | writer's cramp | Neuralgic amyotrophy | Glossopharyngeal neuralgia | Neuralgia | Postzoster neuralgia | Atypical facial neuralgia | facial neuralgia | Social neurosis | Neurasthenia | Atopic neurodermatitis | Circumscribed neurodermatitis | Diffuse neurodermatitis | Neoplastic neuromyopathy | Paraneoplastic neuromyopathy | Carcinomatous neuromyopathy | Neuromyotonia (Isaac's) | Diabetic autonomic neuropathy | Idiopathic peripheral autonomic | Sensory neuropathy dominantly inherited | Sensory neuropathy recessively inherited | Sensorial paraneoplastic neuropathy | Amyloid autonomic neuropathy | heart contractility | manual lymph drainage | Nervousness | personalized oncology | generalized epilepsy | Hypertrophic neuropathy of infancy | Hereditary neuropathy | Hereditary sensory neuropathy | Hereditary motor neuropathy | Hereditary motor and sensory neuropathy | Hereditary and idiopathic neuropathy | Intercostal neuropathy | Uraemic neuropathy | Ischaemic optic neuropathy | Sensorial paraneoplastic neuropathy (Denny Brown) | Idiopathic neuropathy | Idiopathic progressive neuropathy | Serum neuropathy | Idiopathic peripheral autonomie neuropathy | Autonomie neuropathy in metabolic diseases | Autonomie neuropathy in endocrine diseases | Amyloid autonomie neuropathy | Neuropathy in association with hereditary ataxia | Cyclic neutropenia | Neutropenia | Drug-induced neutropenia | Transient neonatal neutropenia | Splenic (primary) neutropenia | Toxic neutropenia | Congenital neutropenia | Combined immunodeficiencies | Lecithin cholesterol acyltransferase deficiency | morphogenesis | airborne allergens | atopy patch test {APT} | Cutaneous T-cell lymphomas {CTCL} | regional cerebral blood flow {rCBF} | immune response modifiers | systemic disease | senile depression | depressive syndrome | cerebral metabolic rate | cerebral blood flow | chimeric proteins | fluid-attenuated inversion recovery {FLAIR} | FLAIR technique | recombinant human proteins | Region al cerebral metabolic rate {rCMR} | blood oxygen level-dependent {BOLD} | cognitive therapy | cognitive behaviour | cognitive neuroscience | Dermatoglyph | electrodermal activity {EDA} | Galvanic skin response {GSR} | psychogalvanic reflex {PGR} | skin conductance response {SCR} | event-related potentials, {ERP} | excitatory postsynaptic potential {EPSP} | Post-stroke depression | inhibitory postsynaptic potential {IPSP} | functional magnetic resonance imaging {fMRI} | regional blood volume {rCBV} | regional oxygen extraction fraction {rOEF} | oxygen consumption {CMRO2} | cerebral metabolic rate of glucose consumption {CMRGlu} | proton magnetic resonance spectroscopy {1H-MRS} | transcranial magnetic stimulation {TMS} | cognitive science {CS}) | Regional Mean Transit Time {rMTT} | Time to Peak {TTP} | aphasia | self-esteem | senile amyloidosis | transient ischaemic attack {TIA} | amyloidosis of aging | anosognosia | Asymptomatic stroke | Basal ganglia lesion | bereavement reaction | cognitive behavioural therapy {CBT} | community sample | confirmatory study | Depressive episode criteria {F32} | coping mechanism | experimental confirmatory clinical trial | frontal area | frontal brain area | hereditary factor | Acute Stress Disorder {ASD} | hypomanic episode |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
